SNOASonoma Pharmaceuticals, Inc.

Nasdaq sonomapharma.com


$ 4.34 $ -0.90 (-17.31 %)    

Wednesday, 18-Sep-2024 15:58:56 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 4.3
$ 5.13
$ 3.75 x 111
-- x --
$ 3.88 - $ 5.13
$ 2.32 - $ 18.20
1,786,045
na
4.12M
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 06-17-2024 03-31-2024 10-K
3 02-08-2024 12-31-2023 10-Q
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 06-21-2023 03-31-2023 10-K
7 02-14-2023 12-31-2022 10-Q
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 07-13-2022 03-31-2022 10-K
11 02-11-2022 12-31-2021 10-Q
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 07-14-2021 03-31-2021 10-K
15 02-16-2021 12-31-2020 10-Q
16 11-20-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 07-10-2020 03-31-2020 10-K
19 02-14-2020 12-31-2019 10-Q
20 11-14-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 07-01-2019 03-31-2019 10-K
23 02-14-2019 12-31-2018 10-Q
24 11-08-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 06-26-2018 03-31-2018 10-K
27 02-14-2018 12-31-2017 10-Q
28 11-14-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 06-28-2017 03-31-2017 10-K
31 02-17-2017 12-31-2016 10-Q
32 11-15-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 06-21-2016 03-31-2016 10-K
35 02-16-2016 12-31-2015 10-Q
36 11-10-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 06-16-2015 03-31-2015 10-K
39 02-12-2015 12-31-2014 10-Q
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonoma-pharmaceuticals-has-been-granted-fda-510k-clearance-for-its-microdacyn-wound-care-solution

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K233399

 sonoma-pharmaceuticals-and-emc-pharma-announce-collaboration-to-co-market-an-expanded-eye-care-product-line-will-also-feature-refreshed-design-and-improved-packaging-for-ocucyn-eyelid--eyelash-cleanser

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...

 why-sonoma-pharmaceuticals-snoa-stock-is-moving

Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.

 sonoma-pharmaceuticals-partners-with-global-healthcare-distributor-for-distribution-of-wound-care-products-in-the-us

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...

 sonoma-pharmaceuticals-q1-eps-007-misses-006-estimate-sales-339m-miss-394m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate...

 sonoma-pharmaceuticals-partners-with-smart-healthcare-to-distribute-wound-care-products-in-ukraine

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...

 sonoma-pharmaceuticals-q4-eps-007-up-from-031-yoy-sales-344m-miss-398m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over loss...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION